149 related articles for article (PubMed ID: 32307566)
1. Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myeloma.
Migkou M; Avivi I; Gavriatopoulou M; Cohen YC; Fotiou D; Kanellias N; Ziogas D; Eleutherakis-Papaiakovou E; Terpos E; Roussou M; Kastritis E; Dimopoulos MA
Ann Hematol; 2020 Jun; 99(6):1251-1255. PubMed ID: 32307566
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of serum free light chains κ/λ ratio and heavy/light chain pairs of immunoglobulin to the stratification of multiple myeloma according to Mayo Stratification of Myeloma and Revised International Staging System].
Ščudla V; Balcárková J; Lochman P; Vincová M; Pika T; Minařík J; Zapletalová J; Jarošová M
Vnitr Lek; 2016 Apr; 62(4):269-80. PubMed ID: 27250604
[TBL] [Abstract][Full Text] [Related]
3. The evolving use of serum free light chain assays in haematology.
Pratt G
Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757
[TBL] [Abstract][Full Text] [Related]
4. [Serum free light chains for diagnosis and follow-up of multiple myeloma].
Jung S; Kim M; Lim J; Kim Y; Han K; Min CK; Min WS
Korean J Lab Med; 2008 Jun; 28(3):169-73. PubMed ID: 18594166
[TBL] [Abstract][Full Text] [Related]
5. Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry.
Wålinder G; Samuelsson J; Näsman P; Hansson M; Juliusson G; Forsberg K; Svensson R; Linder O; Carlson K; Kristinsson SY; Mellqvist UH; Hveding Blimark C; Turesson I; Nahi H
Eur J Haematol; 2020 May; 104(5):376-382. PubMed ID: 31733147
[TBL] [Abstract][Full Text] [Related]
6. High incidence of intact or fragmented immunoglobulin in urine of patients with multiple myeloma.
Kraj M; Kruk B; Lech-Marańda E; Warzocha K; Prochorec-Sobieszek M
Leuk Lymphoma; 2015; 56(12):3348-56. PubMed ID: 25860239
[TBL] [Abstract][Full Text] [Related]
7. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
Dispenzieri A; Kyle R; Merlini G; Miguel JS; Ludwig H; Hajek R; Palumbo A; Jagannath S; Blade J; Lonial S; Dimopoulos M; Comenzo R; Einsele H; Barlogie B; Anderson K; Gertz M; Harousseau JL; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Richardson P; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Rajkumar SV; Durie BG;
Leukemia; 2009 Feb; 23(2):215-24. PubMed ID: 19020545
[TBL] [Abstract][Full Text] [Related]
8. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of a free light chain immunoassay in serum for the diagnosis and the follow-up of monoclonal gammopathy].
Guenet L; Decaux O; Lechartier H; Ropert M; Grosbois B
Rev Med Interne; 2007 Oct; 28(10):689-97. PubMed ID: 17566612
[TBL] [Abstract][Full Text] [Related]
11. Serum free light chains for monitoring multiple myeloma.
Mead GP; Carr-Smith HD; Drayson MT; Morgan GJ; Child JA; Bradwell AR
Br J Haematol; 2004 Aug; 126(3):348-54. PubMed ID: 15257706
[TBL] [Abstract][Full Text] [Related]
12. Clinical course and prognosis of non-secretory multiple myeloma.
Chawla SS; Kumar SK; Dispenzieri A; Greenberg AJ; Larson DR; Kyle RA; Lacy MQ; Gertz MA; Rajkumar SV
Eur J Haematol; 2015 Jul; 95(1):57-64. PubMed ID: 25382589
[TBL] [Abstract][Full Text] [Related]
13. Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation.
Mösbauer U; Ayuk F; Schieder H; Lioznov M; Zander AR; Kröger N
Haematologica; 2007 Feb; 92(2):275-6. PubMed ID: 17296589
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and monitoring of oligosecretory myeloma.
Larson D; Kyle RA; Rajkumar SV
N Engl J Med; 2012 Aug; 367(6):580-1. PubMed ID: 22873553
[No Abstract] [Full Text] [Related]
15. Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcome.
Avivi I; Cohen YC; Joffe E; Benyamini N; Held-Kuznetsov V; Trestman S; Terpos E; Dimopoulos MA; Kastritis E
Hematol Oncol; 2017 Dec; 35(4):734-740. PubMed ID: 27641057
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.
García de Veas Silva JL; Bermudo Guitarte C; Menéndez Valladares P; Rojas Noboa JC; Kestler K; Duro Millán R
PLoS One; 2016; 11(11):e0166841. PubMed ID: 27893836
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performances of M-protein tests according to the clinical presentations of kidney disease.
Koo EH; Shin JH; Jang HR; Park HD; Kwon GY; Huh W; Kim DJ; Kim YG; Oh HY; Lee JE
Eur J Intern Med; 2016 Sep; 33():88-92. PubMed ID: 27421913
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests.
Heaney JLJ; Campbell JP; Griffin AE; Birtwistle J; Shemar M; Child JA; Gregory WM; Cairns DA; Morgan G; Jackson G; Drayson MT
Br J Haematol; 2017 Jul; 178(2):220-230. PubMed ID: 28573706
[TBL] [Abstract][Full Text] [Related]
20. Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein.
Tschautscher M; Rajkumar V; Dispenzieri A; Lacy M; Gertz M; Buadi F; Dingli D; Hwa L; Fonder A; Hobbs M; Hayman S; Zeldenrust S; Lust J; Russell S; Leung N; Kapoor P; Go R; Lin Y; Gonsalves W; Kourelis T; Warsame R; Kyle R; Kumar S
Am J Hematol; 2018 Oct; 93(10):1207-1210. PubMed ID: 30016549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
